Cooper Tire & Rubber Company (CTB) Fundamental Analysis & Valuation

NYSE:CTB

Current stock price

60.17
-0.03 (-0.05%)
At close:
60.17
0 (0%)
After Hours:

This CTB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CTB Profitability Analysis

1.1 Basic Checks

  • In the past year CTB was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 5.97%
ROE 12.4%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 10.39%
PM (TTM) 6.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CTB Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for CTB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • An Altman-Z score of 3.94 indicates that CTB is not in any danger for bankruptcy at the moment.
  • CTB has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 3.94
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • CTB has a Current Ratio of 2.44. This indicates that CTB is financially healthy and has no problem in meeting its short term obligations.
  • CTB has a Quick Ratio of 1.72. This is a normal value and indicates that CTB is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.72

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CTB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 124.52% over the past year.
  • CTB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.24% yearly.
  • The Revenue has decreased by -0.75% in the past year.
  • The Revenue has been decreasing by -3.24% on average over the past years.
EPS 1Y (TTM)124.52%
EPS 3Y-3.11%
EPS 5Y-5.24%
EPS Q2Q%286.96%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-4.06%
Revenue growth 5Y-3.24%
Sales Q2Q%23.35%

3.2 Future

  • Based on estimates for the next years, CTB will show a very strong growth in Earnings Per Share. The EPS will grow by 31.46% on average per year.
  • Based on estimates for the next years, CTB will show a quite strong growth in Revenue. The Revenue will grow by 11.63% on average per year.
EPS Next Y52.22%
EPS Next 2Y33.82%
EPS Next 3Y32.03%
EPS Next 5Y31.46%
Revenue Next Year18.85%
Revenue Next 2Y11.95%
Revenue Next 3Y11.46%
Revenue Next 5Y11.63%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTB Yearly Revenue VS EstimatesCTB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
CTB Yearly EPS VS EstimatesCTB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

4

4. CTB Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.29 indicates a rather expensive valuation of CTB.
  • CTB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.38.
  • Based on the Price/Forward Earnings ratio of 11.91, the valuation of CTB can be described as reasonable.
  • CTB is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.29
Fwd PE 11.91
CTB Price Earnings VS Forward Price EarningsCTB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.14
CTB Per share dataCTB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CTB's earnings are expected to grow with 32.03% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y33.82%
EPS Next 3Y32.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. CTB Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.70%, CTB is not a good candidate for dividend investing.
  • With a Dividend Yield of 0.70, CTB pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

  • CTB has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0%
Div Incr YearsN/A
Div Non Decr YearsN/A
CTB Yearly Dividends per shareCTB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 0.1 0.2 0.3 0.4

5.3 Sustainability

DPN/A
EPS Next 2Y33.82%
EPS Next 3Y32.03%

More info and screens

Find the best dividend stocksShow peers with best dividend

CTB Fundamentals: All Metrics, Ratios and Statistics

Cooper Tire & Rubber Company

NYSE:CTB (6/4/2021, 8:04:01 PM)

After market: 60.17 0 (0%)

60.17

-0.03 (-0.05%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1%
Ins Owner Change0%
Market Cap3.04B
Revenue(TTM)2.65B
Net Income(TTM)176.44M
Analysts60
Price Target53.04 (-11.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly Dividend0.42
Dividend Growth(5Y)0%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.29
Fwd PE 11.91
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 2.14
P/tB N/A
EV/EBITDA 6.14
EPS(TTM)3.48
EY5.78%
EPS(NY)5.05
Fwd EY8.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS52.36
BVpS28.16
TBVpSN/A
PEG (NY)0.33
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 5.97%
ROE 12.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 10.39%
PM (TTM) 6.67%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 1.72
Altman-Z 3.94
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)124.52%
EPS 3Y-3.11%
EPS 5Y-5.24%
EPS Q2Q%286.96%
EPS Next Y52.22%
EPS Next 2Y33.82%
EPS Next 3Y32.03%
EPS Next 5Y31.46%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-4.06%
Revenue growth 5Y-3.24%
Sales Q2Q%23.35%
Revenue Next Year18.85%
Revenue Next 2Y11.95%
Revenue Next 3Y11.46%
Revenue Next 5Y11.63%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Cooper Tire & Rubber Company / CTB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Cooper Tire & Rubber Company?

ChartMill assigns a fundamental rating of 7 / 10 to CTB.


Can you provide the valuation status for Cooper Tire & Rubber Company?

ChartMill assigns a valuation rating of 6 / 10 to Cooper Tire & Rubber Company (CTB). This can be considered as Fairly Valued.


How profitable is Cooper Tire & Rubber Company (CTB) stock?

Cooper Tire & Rubber Company (CTB) has a profitability rating of 7 / 10.


How financially healthy is Cooper Tire & Rubber Company?

The financial health rating of Cooper Tire & Rubber Company (CTB) is 9 / 10.